GENELABS TECHNOLOGIES INC Contracts & Agreements

20 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Entry into a Material Definitive Agreement
GENELABS TECHNOLOGIES INC
2008
Entry into a Material Definitive Agreement
GENELABS TECHNOLOGIES INC
2008
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
GENELABS TECHNOLOGIES INC
2008
SEPARATION AGREEMENT ANDGENERAL RELEASE
Separation Agreements
GENELABS TECHNOLOGIES INC
CA
2008
Form of Warrant THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 4 OF THIS WARRANT
Stock Agreements
GENELABS TECHNOLOGIES INC
2007
our ability to secure sufficient funds as a going concern
GENELABS TECHNOLOGIES INC
2007
our ability to secure sufficient funds as a going concern
GENELABS TECHNOLOGIES INC
NY
2007
FORM OF SECURITIES PURCHASE AGREEMENT
Purchase Agreements
GENELABS TECHNOLOGIES INC
NY
2007
our ability to remain listed on the Nasdaq Capital Market
GENELABS TECHNOLOGIES INC
2006
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
GENELABS TECHNOLOGIES INC
2006
Dr. Ahmeds employment with Genelabs terminated on June 15, 2006
Employment Agreements
GENELABS TECHNOLOGIES INC
CA
2006
Dr. Ahmeds employment with Genelabs terminated on June 15, 2006
Employment Agreements
GENELABS TECHNOLOGIES INC
CA
2006
our ability to secure sufficient funds to continue as a going concern
GENELABS TECHNOLOGIES INC
2006
our ability to secure sufficient funds to continue as a going concern
GENELABS TECHNOLOGIES INC
2006
our ability to secure sufficient funds to continue as a going concern
GENELABS TECHNOLOGIES INC
CA
2006
results and analysis of our recent Prestara Phase III clinical trial in the United States and the follow-on open label clinical trial
GENELABS TECHNOLOGIES INC
2004
estimates relating to the timing and completion of our pending clinical trials
GENELABS TECHNOLOGIES INC
2004
estimates relating to our cash resources and our ability to obtain additional funding for our business plans
Funding Agreements
GENELABS TECHNOLOGIES INC
CA
2003
potential FDA actions with respect to our NDA for Prestara (formerly Aslera or GL701), including whether or not the Prestara NDA ultimately will receive marketing approval and the...
Marketing Agreements
GENELABS TECHNOLOGIES INC
2002
potential FDA actions with respect to our NDA for Prestara (formerly Aslera or GL701), including whether or not the Prestara NDA ultimately will receive marketing approval and the...
Marketing Agreements
GENELABS TECHNOLOGIES INC
2002